Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Institut Bergonié
Intensity Therapeutics, Inc.
Ipsen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hutchmed
University of Virginia
Hoffmann-La Roche
City of Hope Medical Center
Ludwig Institute for Cancer Research
Novartis
University of South Florida
Amgen
M.D. Anderson Cancer Center
The University of Texas Health Science Center, Houston
Mayo Clinic
Columbia University
University of South Florida
Dana-Farber Cancer Institute
INSYS Therapeutics Inc